GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (NAS:IDXX) » Definitions » Price-to-Owner-Earnings

IDEXX Laboratories (IDEXX Laboratories) Price-to-Owner-Earnings

: 55.56 (As of Today)
View and export this data going back to 1991. Start your Free Trial

As of today (2024-04-17), IDEXX Laboratories's share price is $477.84. IDEXX Laboratories's Owner Earnings per Share (TTM) ended in Dec. 2023 was $8.60. It's Price-to-Owner-Earnings for today is 55.56.


The historical rank and industry rank for IDEXX Laboratories's Price-to-Owner-Earnings or its related term are showing as below:

IDXX' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 25.61   Med: 61.75   Max: 114.13
Current: 55.65

During the past 13 years, the highest Price-to-Owner-Earnings of IDEXX Laboratories was 114.13. The lowest was 25.61. And the median was 61.75.


IDXX's Price-to-Owner-Earnings is ranked worse than
82.09% of 67 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.37 vs IDXX: 55.65

As of today (2024-04-17), IDEXX Laboratories's share price is $477.84. IDEXX Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $10.07. Therefore, IDEXX Laboratories's PE Ratio for today is 47.45.

As of today (2024-04-17), IDEXX Laboratories's share price is $477.84. IDEXX Laboratories's EPS without NRI for the trailing twelve months (TTM) ended in was $10.12. Therefore, IDEXX Laboratories's PE Ratio without NRI for today is 47.22.

During the past 13 years, IDEXX Laboratories's highest PE Ratio without NRI was 86.72. The lowest was 25.29. And the median was 52.20.


IDEXX Laboratories Price-to-Owner-Earnings Historical Data

The historical data trend for IDEXX Laboratories's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.81 84.21 93.33 93.78 64.57

IDEXX Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 93.78 97.56 74.64 56.80 64.57

Competitive Comparison

For the Diagnostics & Research subindustry, IDEXX Laboratories's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories Price-to-Owner-Earnings Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Price-to-Owner-Earnings falls into.



IDEXX Laboratories Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

IDEXX Laboratories's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=477.84/8.60
=55.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IDEXX Laboratories  (NAS:IDXX) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


IDEXX Laboratories Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (IDEXX Laboratories) Business Description

Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.
Executives
James F Polewaczyk officer: Corporate Vice President IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Jonathan Jay Mazelsky director, officer: President and CEO ONE IDEXX DRIVE, WESTBROOK ME 04092
Martin Alexander Smith officer: Executive Vice President C/O IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Jonathan W Ayers director, officer: President & CEO IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Michael Lane officer: Executive Vice President C/O IDEXX LABORATORIES, INC., WESTBROOK ME 04092
Irene Chang Britt director CAMPBELL SOUP COMPANY, ONE CAMPBELL PLACE, CAMDEN NJ 08103
Bruce L. Claflin director 7035 RIDGE ROAD, HANOVER MD 21076
Samer Abdul Samad director 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Lawrence D Kingsley director C/O IDEX CORPORATION, 630 DUNDEE ROAD, NORTHBROOK IL 60062
Asha Collins director IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
M Anne Szostak director C/O TUPPERWARE BRANDS CORP, 14901 S ORANGE BLOSSOM TR, ORLANDO FL 32837
Sharon E. Underberg officer: EVP, GC & Corporate Secretary EASTMAN KODAK COMPANY, 343 STATE STREET, ROCHESTER NY 14650
Sophie V. Vandebroek director 6 OAK MEADOW ROAD, LINCOLN MA 01770
Daniel M Junius director C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451